ArticleLung Cancer (Auckland, N.Z.)2021

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.

Giannis Mountzios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.